About us
our history
Ampliphi Bio was founded in 2014 with a clear vision: to become a trusted Contract Development and Manufacturing Organization for biologics. In 2015, we achieved our first GMP certification for biologics production, quickly followed by certification for Advanced Therapy Medicinal Products (ATMPs). That same year, we manufactured our first clinical trial material, successfully used in the United States and Australia.
Since then, Ampliphi Bio has continued to grow as a global partner in biologics development and GMP manufacturing, producing multiple clinical trial batches for studies across the EU, US and Australia. Our innovative R&D team has designed platform production processes tailored to the unique needs of gene therapy and cell therapy, enabling fast turnaround times (3-4 weeks) and cost-efficient solutions for personalized medicine.
why choose us
our mission
Where Science, Quality and Teamwork Come Together
At Ampliphi Bio, our mission is to advance the development and GMP manufacturing of biologics that power gene therapy, cell therapy, and personalized medicine. We deliver scalable, reliable, and compliant CDMO solutions—from pDNA and mRNA production to aseptic Fill & Finish.
Our greatest strength is our team. With deep scientific expertise, regulatory knowledge, and a strong commitment to quality, we work closely with our partners to ensure every project moves smoothly from lab to clinic. Together, we strive to transform innovative research into life-changing therapies for patients worldwide.